Search Results

Filter
  • 1-10 of  1,387 results for ""BLOOD coagulation factors""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Four-factor prothrombin complex concentrate versus andexanet alfa for direct oral anticoagulant reversal.

Subjects: Anticoagulation Reversal* ; Blood Coagulation Factors*/Blood Coagulation Factors*/Blood Coagulation Factors*/adverse effects ; Blood Coagulation Factors*/Blood Coagulation Factors*/Blood Coagulation Factors*/therapeutic use

  • Source: Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2024 Mar-Apr; Vol. 64 (2), pp. 395-401. Date of Electronic Publication: 2023 Nov 11.Publisher: Elsevier Country of Publication: United States NLM ID: 101176252 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Advances and challenges in the purification of recombinant coagulation factors: A review.

  • Authors : Yu L; Department of Biochemical Engineering, School of Chemical Engineering and Technology, Key Laboratory of Systems Bioengineering and Frontiers Science Center for Synthetic Biology (Ministry of Education), Tianjin University, Tianjin 300350, China.; Yang D

Subjects: Blood Coagulation Factors* ; Biotechnology*; Humans

  • Source: Journal of chromatography. A [J Chromatogr A] 2024 Feb 08; Vol. 1716, pp. 464662. Date of Electronic Publication: 2024 Jan 16.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9318488 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The breast cancer coagulome in the tumor microenvironment and its role in prognosis and treatment response to chemotherapy.

  • Authors : Tinholt M; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Department of Haematology, Oslo University Hospital, Oslo, Norway. Electronic address: .

Subjects: Tumor Microenvironment* ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/genetics

  • Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 May; Vol. 22 (5), pp. 1319-1335. Date of Electronic Publication: 2024 Jan 17.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Comparative analysis of andexanet alfa and prothrombin complex concentrate in reversing anticoagulation by rivaroxaban ex vivo.

  • Authors : Rayatdoost F; Department of Anaesthesiology, RWTH Aachen University Hospital, Aachen, Germany.; Deventer K

Subjects: Hemostatics*/Hemostatics*/Hemostatics*/therapeutic use ; Rivaroxaban*/Rivaroxaban*/Rivaroxaban*/pharmacology; Humans

  • Source: British journal of anaesthesia [Br J Anaesth] 2024 Feb; Vol. 132 (2), pp. 251-259. Date of Electronic Publication: 2023 Nov 28.Publisher: Elsevier Country of Publication: England NLM ID: 0372541 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Andexanet alfa or prothrombin complex concentrate for acute reversal of oral factor Xa inhibitors: monitoring of antidote effects.

  • Authors : Tanaka KA; Department of Anesthesiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: .; Levy JH

Subjects: Factor Xa Inhibitors*/Factor Xa Inhibitors*/Factor Xa Inhibitors*/pharmacology ; Antidotes*/Antidotes*/Antidotes*/pharmacology ; Antidotes*/Antidotes*/Antidotes*/therapeutic use

  • Source: British journal of anaesthesia [Br J Anaesth] 2024 Feb; Vol. 132 (2), pp. 215-217. Date of Electronic Publication: 2023 Dec 08.Publisher: Elsevier Country of Publication: England NLM ID: 0372541 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Reversal of pre-injury factor-Xa inhibitors with prothrombin complex concentrates in patients following traumatic brain injury.

  • Authors : Barletta JF; Midwestern University, College of Pharmacy, Glendale Campus, 19555 N 59th Avenue, Glendale, AZ 85308, USA. Electronic address: .; Shirah GR

Subjects: Factor Xa Inhibitors* ; Brain Injuries, Traumatic*/Brain Injuries, Traumatic*/Brain Injuries, Traumatic*/drug therapy ; Brain Injuries, Traumatic*/Brain Injuries, Traumatic*/Brain Injuries, Traumatic*/complications

  • Source: Clinical neurology and neurosurgery [Clin Neurol Neurosurg] 2023 Dec; Vol. 235, pp. 108040. Date of Electronic Publication: 2023 Nov 03.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502039 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Cellular stress and coagulation factor production: when more is not necessarily better.

  • Authors : Chen Z; Degenerative Diseases Program, Center for Genetic Diseases and Aging Research, SBP Medical Discovery Institute, California, USA.; Herzog RW

Subjects: Hemophilia A*/Hemophilia A*/Hemophilia A*/genetics ; Hemophilia A*/Hemophilia A*/Hemophilia A*/therapy ; Hemophilia A*/Hemophilia A*/Hemophilia A*/metabolism

  • Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2023 Dec; Vol. 21 (12), pp. 3329-3341. Date of Electronic Publication: 2023 Oct 14.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Unraveling coagulation factor-mediated cellular signaling.

  • Authors : O'Donnell JS; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland; National Children's Research Centre, Children's Health Ireland, Crumlin, Dublin, Ireland. Electronic address: https://twitter.com/profJSOdonnell.

Subjects: Thrombin*/Thrombin*/Thrombin*/metabolism ; Hematologic Agents*; Humans

  • Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2023 Dec; Vol. 21 (12), pp. 3342-3353. Date of Electronic Publication: 2023 Jun 28.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Impact of fibrinogen and prothrombin complex concentrate on clotting time in a model of obstetric hemorrhage.

  • Authors : Katz DJ; Department of Anesthesiology, Pain, & Perioperative Medicine at the Icahn School of Medicine at Mount Sinai, NY, NY, United States; Department of Obstetrics, Gynecology, & Reproductive Sciences at the Icahn School of Medicine at Mount Sinai, NY, NY, United States. Electronic address: .

Subjects: Blood Coagulation* ; Blood Coagulation Factors*/Blood Coagulation Factors*/Blood Coagulation Factors*/therapeutic use ; Fibrinogen*/Fibrinogen*/Fibrinogen*/therapeutic use

  • Source: Journal of clinical anesthesia [J Clin Anesth] 2022 Jun; Vol. 78, pp. 110687. Date of Electronic Publication: 2022 Feb 17.Publisher: Elsevier Country of Publication: United States NLM ID: 8812166 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Complement and coagulation crosstalk - Factor H in the spotlight.

  • Authors : Heurich M; School of Pharmacy and Pharmaceutical Sciences, College of Biomedical and Life Sciences, Cardiff University, United Kingdom. Electronic address: .; McCluskey G

Subjects: Complement Factor H* ; Thrombosis*; Humans

  • Source: Immunobiology [Immunobiology] 2023 Nov; Vol. 228 (6), pp. 152707. Date of Electronic Publication: 2023 Jul 12.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8002742 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  1,387 results for ""BLOOD coagulation factors""